CHRNA4 and alcohol dependence: Thus, our data give further support to the idea that UFR2709, a nAChR antagonist, may be a novel therapeutic agent for the treatment of alcoholism, and highlight nAChRs as potential targets for the design of drugs aimed to reduce ethanol intake.